Thrombinn.凝血酶
Rivaroxabann.利伐沙班
Heartfailureisassociatedwithactivationofthrombin-relatedpathways,whichpredictsapoorprognosis.IntheCOMMANDERHFTrial,patientswhohadchronicheartfailure,aleftventricularejectionfractionof40%orless,coronaryarterydisease,andelevatedplasmaconcentrationsofnatriureticpeptidesandwhodidnothaveatrialfibrillationwererandomlyassignedtoreceiverivaroxabanatadoseof2.5mgtwicedailyorplaceboinadditiontostandardcareaftertreatmentforanepisodeofworseningheartfailure.Overamedianfollow-upperiodof21.1months,theprimaryendpointofdeathfromanycause,myocardialinfarction,orstrokeoccurredin25.0%patientsofrivaroxabanand26.2%patientsofplacebo.Nosignificantdifferenceinall-causemortalitywasnotedbetweentherivaroxabangroupandtheplacebogroup(21.8%and22.1%,respectively).Theprincipalsafetyout白癜风形成的原因北京看白癜风好专科医院
转载请注明:http://www.ctongt.com/gbyz/2515.html